University of California San Francisco
Helen Diller Family Comprehensive Cancer Center
Pelin Cinar, MD, MS

Pelin Cinar, MD, MS

Medical Director of Quality and Safety, UCSF Helen Diller Family Comprehensive Cancer Center; Clinical Asst. Professor, Dept. of Gastrointestinal Oncology, UCSF

Selected Publications

  1. Cinar P, Ko AH. Best practices for the treatment of metastatic pancreatic adenocarcinoma: the therapeutic landscape in 2017. Chin Clin Oncol. 2017 Jun; 6(3):29.
    View on PubMed
  2. Cinar P, Calkins SM, Venook AP, Kelley RK. A case series of patients with HER2-overexpressed primary metastatic gastroesophageal adenocarcinoma. Anticancer Res. 2014 Dec; 34(12):7357-60.
    View on PubMed
  3. Cinar P, Ko AH. Evolving treatment options for locally advanced unresectable pancreatic ductal adenocarcinoma. J Natl Compr Canc Netw. 2014 Feb; 12(2):167-72.
    View on PubMed
  4. Cinar P, Tempero MA. Monoclonal antibodies and other targeted therapies for pancreatic cancer. Cancer J. 2012 Nov-Dec; 18(6):653-64.
    View on PubMed
  5. Zell JA, Cinar P, Mobasher M, Ziogas A, Meyskens FL, Anton-Culver H. Survival for patients with invasive cutaneous melanoma among ethnic groups: the effects of socioeconomic status and treatment. J Clin Oncol. 2008 Jan 01; 26(1):66-75.
    View on PubMed

Go to UCSF Profiles, powered by CTSI